Search Within

Carl Ola Landgren

Formats
  1. Meeting Abstract (155)
  2. Journal Article (151)
  3. Review (14)
  4. Research Letter (7)
  5. Book Section (3)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Conference Paper (1)
  9. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (336)
  2. Department of Medicine (336)
  3. Hematologic Malignancies Research (336)
  4. Hematologic Malignancies, Division of (336)
  5. Myeloma (336)
  6. Survivorship Research (132)

More Groups

People
  1. Neha Korde (106)
  2. Sham Mailankody (91)
  3. Alexander Lesokhin (83)
  4. Malin Hultcrantz (81)
  5. Hani Hassoun (77)
  6. Sergio Giralt (73)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (21)
  4. 2020 (52)
  5. 2019 (56)
  6. 2018 (51)

More Years

Publications
  1. Blood (102)
  2. Haematologica (25)
  3. Clinical Lymphoma, Myeloma and Leukemia (21)
  4. Leukemia and Lymphoma (16)
  5. Biology of Blood and Marrow Transplantation (13)
  6. Blood Cancer Journal (10)

More Publications

Publishers
  1. American Society of Hematology (109)
  2. Elsevier Inc. (45)
  3. Nature Publishing Group (29)
  4. Ferrata Storti Foundation (25)
  5. Taylor & Francis Group (17)
  6. American Association for Cancer Research (15)

More Publishers

Results (336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients
    Meeting Abstract

    Mailankody, S.; Korde, N.; Roschewski, M. J.; Christofferson, A.; Boateng, M.; Zhang, Y.; Manasanch, E. E.; Kazandjian, D. G.; Kwok, M.; Bhutani, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Imaging measurable (minimal) residual disease in multiple myeloma
    Journal Article

    Bhutani, M.; Usmani, S. Z.; Taneja, A.; Landgren, O.
    Current Radiology Reports (2016)

    Fulltext@MSK | Save
  • Improved survival in AL amyloidosis: A population-based study on 1,430 patients diagnosed in Sweden 1995-2013
    Meeting Abstract

    Weiss, B. M.; Lund, S. H.; Bjorkholm, M.; Cohen, A. D.; Dember, L.; Landgren, O.; Kristinsson, S. Y.
    Blood (2016)

    Fulltext@MSK | Save
  • The mutational and signaling landscape of multiple myeloma varies dependent upon translocation cyclin D (TC) subgroup
    Meeting Abstract

    Stein, C. K.; Pawlyn, C.; Chavan, S. S.; Weinhold, N.; Walker, B. A.; Rosenthal, A.; Landgren, O.; Bergsagel, P. L.; Morgan, G. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Dietary pattern and risk of monoclonal gammopathy of undetermined significance: A population-based study
    Meeting Abstract

    Thordardottir, M.; Lindqvist, E. K.; Lund, S. H.; Costello, R.; Torfadottir, J. E.; Birgisdottir, B. E.; Burton, D.; Steingrimsdottir, L.; Korde, N. S.; Mailankody, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Risk of progression in monoclonal gammopathy of undetermined significance (MGUS): Results from a population-based screening study
    Meeting Abstract

    Lindqvist, E. K.; Lund, S. H.; Costello, R.; Burton, D.; Korde, N. S.; Mailankody, S.; Björkholm, M.; Eiriksdottir, G.; Launer, L. J.; Harris, T. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Whole exome sequencing from nine independent sites of extraosseous disease in a single patient with relapsed multiple myeloma show that extramedullary disease arise through a combination of branched and parallel evolution
    Meeting Abstract

    Landau, H.; Fan, J.; Giralt, S. A.; Peled, J. U.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) followed by 2 years of lenalidomide maintenance (CRd-R): Updated results of a phase 2 study
    Meeting Abstract

    Kazandjian, D.; Korde, N. S.; Roschewski, M.; Mailankody, S.; Morrison, C.; Manasanch, E. E.; Kwok, M. L.; Tageja, N.; Bhutani, M.; Zingone, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Longitudinal (18)f-FDG-PET-CT analysis in newly diagnosed multiple myeloma (NDMM) patients following carfilzomib, lenalidomide, dexamethasone induction and lenalidomide maintenance (CRd-R)
    Meeting Abstract

    Korde, N. S.; Kazandjian, D.; Roschewski, M.; Mailankody, S.; Hultcrantz, M.; Yuan, C. M.; Stetler-Stevenson, M.; Choyke, P.; Hassoun, H.; Lesokhin, A. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The impact of prior malignancies on second malignancies and survival in MM patients: A population-based study
    Meeting Abstract

    Jonsdottir, G.; Lund, S. H.; Björkholm, M.; Turesson, I.; Wahlin, A.; Hultcrantz, M.; Porwit, A.; Landgren, O.; Kristinsson, S. Y.
    Blood (2016)

    Fulltext@MSK | Save